TE1 fundamentals
An in-depth look to BIO-TECHNE CORP. DL-,01 operating, investing, and financing activities
TE1 free cash flow for Q3 24 is 59.82 M EUR. For 2023, TE1 free cash flow was 198.17 M EUR and operating cash flow was 233.23 M EUR.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM